282 related articles for article (PubMed ID: 32178724)
1. A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.
Alegret M; Muñoz N; Roberto N; Rentz DM; Valero S; Gil S; Marquié M; Hernández I; Riveros C; Sanabria A; Perez-Cordon A; Espinosa A; Ortega G; Mauleón A; Abdelnour C; Rosende-Roca M; Papp KV; Orellana A; Benaque A; Tarraga L; Ruiz A; Boada M
Alzheimers Res Ther; 2020 Mar; 12(1):25. PubMed ID: 32178724
[TBL] [Abstract][Full Text] [Related]
2. Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.
Alegret M; Sotolongo-Grau O; de Antonio EE; Pérez-Cordón A; Orellana A; Espinosa A; Gil S; Jiménez D; Ortega G; Sanabria A; Roberto N; Hernández I; Rosende-Roca M; Tartari JP; Alarcon-Martin E; de Rojas I; Montrreal L; Morató X; Cano A; Rentz DM; Tárraga L; Ruiz A; Valero S; Marquié M; Boada M
Alzheimers Res Ther; 2022 Mar; 14(1):43. PubMed ID: 35303916
[TBL] [Abstract][Full Text] [Related]
3. Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory.
Papp KV; Amariglio RE; Dekhtyar M; Roy K; Wigman S; Bamfo R; Sherman J; Sperling RA; Rentz DM
Clin Neuropsychol; 2014; 28(5):771-85. PubMed ID: 24815535
[TBL] [Abstract][Full Text] [Related]
4. Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects.
Alegret M; Rodríguez O; Espinosa A; Ortega G; Sanabria A; Valero S; Hernández I; Rosende-Roca M; Vargas L; Abdelnour C; Mauleón A; Gailhajanet A; Martín E; Tárraga L; Rentz DM; Amariglio RE; Ruíz A; Boada M
J Alzheimers Dis; 2015; 48(4):1109-17. PubMed ID: 26444795
[TBL] [Abstract][Full Text] [Related]
5. Validation and Normative Data of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME).
Alviarez-Schulze V; Cattaneo G; Pachón-García C; Solana-Sánchez J; Tormos-Muñoz JM; Alegret M; Pascual-Leone A; Bartrés-Faz D;
J Int Neuropsychol Soc; 2022 Jan; 28(1):74-84. PubMed ID: 33749568
[TBL] [Abstract][Full Text] [Related]
6. Performance on the Latin American version of the Face-Name Associative Memory Exam (LAS-FNAME) distinguishes individuals with Mild Cognitive Impairment from age-matched controls in a sample from Argentina.
Keller G; Corvalan N; Carello MA; Arruabarrena MM; Martínez-Canyazo C; De Los Santos L; Spehrs J; Vila-Castelar C; Allegri RF; Quiroz YT; Crivelli L
Appl Neuropsychol Adult; 2024 Mar; ():1-9. PubMed ID: 38447166
[TBL] [Abstract][Full Text] [Related]
7. FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
Alegret M; García-Gutiérrez F; Muñoz N; Espinosa A; Ortega G; Lleonart N; Rodríguez I; Rosende-Roca M; Pytel V; Cantero-Fortiz Y; Rentz DM; Marquié M; Valero S; Ruiz A; Butler C; Boada M
J Alzheimers Dis; 2024; 97(3):1173-1187. PubMed ID: 38217602
[TBL] [Abstract][Full Text] [Related]
8. The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline.
Sanabria A; Alegret M; Rodriguez-Gomez O; Valero S; Sotolongo-Grau O; Monté-Rubio G; Abdelnour C; Espinosa A; Ortega G; Perez-Cordon A; Gailhajanet A; Hernandez I; Rosende-Roca M; Vargas L; Mauleon A; Sanchez D; Martin E; Rentz DM; Lomeña F; Ruiz A; Tarraga L; Boada M;
Sci Rep; 2018 Feb; 8(1):3828. PubMed ID: 29491481
[TBL] [Abstract][Full Text] [Related]
9. Extended FNAME performance is preserved in subjective cognitive decline but highly affected in amnestic mild cognitive impairment.
Flores-Vázquez JF; Contreras-López JJ; Stegeman R; Castellanos-Maya O; Ćurčić-Blake B; Andrés P; Sosa-Ortiz AL; Aleman A; Enriquez-Geppert S
Neuropsychology; 2023 Sep; 37(6):650-660. PubMed ID: 36480377
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals.
Alegret M; Valero S; Ortega G; Espinosa A; Sanabria A; Hernández I; Rodríguez O; Rosende-Roca M; Mauleón A; Vargas L; Martín E; Ruíz A; Tárraga L; Amariglio RE; Rentz DM; Boada M
Arch Clin Neuropsychol; 2015 Nov; 30(7):712-20. PubMed ID: 26289054
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
[TBL] [Abstract][Full Text] [Related]
12. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
[TBL] [Abstract][Full Text] [Related]
13. Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.
Goldstein FC; Loring DW; Thomas T; Saleh S; Hajjar I
J Alzheimers Dis; 2019; 72(2):507-514. PubMed ID: 31594225
[TBL] [Abstract][Full Text] [Related]
14. The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease.
Vila-Castelar C; Muñoz N; Papp KV; Amariglio RE; Baena A; Guzmán-Vélez E; Bocanegra Y; Sanchez JS; Reiman EM; Johnson KA; Sperling RA; Lopera F; Rentz DM; Quiroz YT
Alzheimers Res Ther; 2020 Sep; 12(1):104. PubMed ID: 32912283
[TBL] [Abstract][Full Text] [Related]
15. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of mild cognitive impairment of Alzheimer's disease by Simoa p-tau181 measurements with matching plasma and CSF.
Wu L; Arvai S; Wang SJ; Liu AJ; Xu B
Front Mol Neurosci; 2023; 16():1288930. PubMed ID: 38260807
[TBL] [Abstract][Full Text] [Related]
17. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
[TBL] [Abstract][Full Text] [Related]
19. An Incidental Learning Method to Improve Face-Name Memory in Older Adults With Amnestic Mild Cognitive Impairment.
Biss RK; Rowe G; Hasher L; Murphy KJ
J Int Neuropsychol Soc; 2020 Oct; 26(9):851-859. PubMed ID: 32438935
[TBL] [Abstract][Full Text] [Related]
20. I know your face but can't remember your name: Age-related differences in the FNAME-12NL.
Enriquez-Geppert S; Flores-Vázquez JF; Lietz M; Garcia-Pimenta M; Andrés P
Arch Clin Neuropsychol; 2021 Jul; 36(5):844-849. PubMed ID: 33159522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
